Tailoring Rituximab According to CD27-Positive B-Cell versus CD19-Positive B-Cell Monitoring in Neuromyelitis Optica Spectrum Disorder and MOG-Associated Disease: Results from a Single-Center Study
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource, 1 online resource.
- Sprache
-
Englisch
- Erschienen in
-
Tailoring Rituximab According to CD27-Positive B-Cell versus CD19-Positive B-Cell Monitoring in Neuromyelitis Optica Spectrum Disorder and MOG-Associated Disease: Results from a Single-Center Study ; volume:12 ; number:4 ; day:11 ; month:5 ; year:2023 ; pages:1375-1383 ; date:8.2023
Neurology and Therapy ; 12, Heft 4 (11.5.2023), 1375-1383, 8.2023
- Urheber
-
Bruschi, Nicolò
Malentacchi, Maria
Malucchi, Simona
Sperli, Francesca
Martire, Serena
Sala, Arianna
Valentino, Paola
Bertolotto, Antonio
Pautasso, Marisa
Capobianco, Marco Alfonso
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s40120-023-00481-w
- URN
-
urn:nbn:de:101:1-2023092910321858060614
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:01 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Bruschi, Nicolò
- Malentacchi, Maria
- Malucchi, Simona
- Sperli, Francesca
- Martire, Serena
- Sala, Arianna
- Valentino, Paola
- Bertolotto, Antonio
- Pautasso, Marisa
- Capobianco, Marco Alfonso
- SpringerLink (Online service)
Ähnliche Objekte (12)
Peripheral CD19+ B-cell counts and infusion intervals as a surrogate for long-term B-cell depleting therapy in multiple sclerosis and neuromyelitis optica/neuromyelitis optica spectrum disorders
An unusual case of Epstein-Barr virus-positive large B-cell lymphoma lacking various B-cell markers
CD19-immunoPET for noninvasive visualization of CD19 expression in B-cell lymphoma patients
Distribution of chimeric antigen receptor-modified T cells against CD19 in B-cell malignancies
How we treat mature B-cell neoplasms (indolent B-cell lymphomas)
ALK-positive large B-cell lymphoma (ALK + LBCL) with aberrant CD3 expression
Maladaptive positive feedback production of ChREBPβ underlies glucotoxic β-cell failure
TriBAFF-CAR-T cells eliminate B-cell malignancies with BAFFR-expression and CD19 antigen loss
CD19-negative relapse of pediatric B-cell precursor acute lymphoblastic leukemia following blinatumomab treatment
Risk factors in DUX4-positive childhood and adolescent B-cell acute lymphoblastic leukemia
FDG-PET in HIV-Positive Patient with Extranodal Diffuse Large B-Cell Lymphoma
Breast implant associated EBV-positive Diffuse Large B-cell lymphoma: an underrecognized entity?
Peripheral CD19+ B-cell counts and infusion intervals as a surrogate for long-term B-cell depleting therapy in multiple sclerosis and neuromyelitis optica/neuromyelitis optica spectrum disorders
An unusual case of Epstein-Barr virus-positive large B-cell lymphoma lacking various B-cell markers
CD19-immunoPET for noninvasive visualization of CD19 expression in B-cell lymphoma patients
Distribution of chimeric antigen receptor-modified T cells against CD19 in B-cell malignancies
How we treat mature B-cell neoplasms (indolent B-cell lymphomas)
ALK-positive large B-cell lymphoma (ALK + LBCL) with aberrant CD3 expression
Maladaptive positive feedback production of ChREBPβ underlies glucotoxic β-cell failure
TriBAFF-CAR-T cells eliminate B-cell malignancies with BAFFR-expression and CD19 antigen loss
CD19-negative relapse of pediatric B-cell precursor acute lymphoblastic leukemia following blinatumomab treatment
Risk factors in DUX4-positive childhood and adolescent B-cell acute lymphoblastic leukemia
FDG-PET in HIV-Positive Patient with Extranodal Diffuse Large B-Cell Lymphoma
Breast implant associated EBV-positive Diffuse Large B-cell lymphoma: an underrecognized entity?
Peripheral CD19+ B-cell counts and infusion intervals as a surrogate for long-term B-cell depleting therapy in multiple sclerosis and neuromyelitis optica/neuromyelitis optica spectrum disorders
An unusual case of Epstein-Barr virus-positive large B-cell lymphoma lacking various B-cell markers
CD19-immunoPET for noninvasive visualization of CD19 expression in B-cell lymphoma patients
Distribution of chimeric antigen receptor-modified T cells against CD19 in B-cell malignancies
How we treat mature B-cell neoplasms (indolent B-cell lymphomas)
ALK-positive large B-cell lymphoma (ALK + LBCL) with aberrant CD3 expression
Maladaptive positive feedback production of ChREBPβ underlies glucotoxic β-cell failure
TriBAFF-CAR-T cells eliminate B-cell malignancies with BAFFR-expression and CD19 antigen loss
CD19-negative relapse of pediatric B-cell precursor acute lymphoblastic leukemia following blinatumomab treatment
Risk factors in DUX4-positive childhood and adolescent B-cell acute lymphoblastic leukemia
FDG-PET in HIV-Positive Patient with Extranodal Diffuse Large B-Cell Lymphoma